Skip to main content
. 2022 Aug 30;12(8):e058277. doi: 10.1136/bmjopen-2021-058277

Table 1.

Baseline clinical characteristics by tertiles of self-rated health

Tertiles of self-rated health
1st tertile (n=231) 2nd tertile (n=226) 3rd tertile (n=117) P trend*
0 to 70 71 to 90 91 to 100
Baseline
 Age, years 46±16 38±13 39±15 <0.001
 Female, % 154 (67%) 127 (56) 69 (59) 0.06
 Self-reported race, % 0.51
   White 33 (14) 24 (11) 20 (17)
   Mixed 163 (71) 175 (77) 77 (66)
   Black 32 (14) 26 (12) 18 (15)
   Indigenous 2 (1) 1 (<1) 1 (1)
 BMI, kg/m2 28±6 27±5 26±4 0.002
 Abdominal circumference, cm 90±14 87±12 84±11 <0.001
 Asthma, % 11 (5) 8 (4) 2 (2) 0.36
 COPD, % 3 (1) 3 (1) 1 (1) 0.92
 History of MI, % 2 (1) 2 (1) 1 (1) 1
 Heart failure, % 3 (1) 2 (1) 0 (0) 0.47
 Rheumatic heart disease, % 7 (3) 7 (3) 4 (3) 0.97
 SBP, mmHg 134±20 131±20 131±19 0.29
 DBP, mmHg 83±12 81±11 82±12 0.17
Risk factors
 Hypertension, % 66 (29) 32 (14) 14 (12) <0.001
 Hypercholesterolaemia, % 52 (23) 23 (10) 14 (12) <0.001
 Diabetes, % 21 (9) 6 (3) 6 (5) 0.012
 Obesity, % 68 (29) 45 (20) 20 (17) 0.012
 Smoking, % 106 (46) 65 (29) 46 (39) <0.001
 Healthy diet, % 87 (38) 130 (58) 59 (50) <0.001
 Physical activity, % 64 (28) 94 (42) 53 (45) <0.001
Socioeconomic status
 Work status, % 0.09
   Employed 77 (33) 98 (43) 53 (45)
   Self-employed 20 (9) 23 (10) 9 (8)
   Other 134 (58) 105 (47) 55 (47)
 Family income, BRL 1250(800, 2000) 1500(1000, 3000) 1200(800, 2000) 0.11
 Rural living area, % 92 (40) 78 (35) 55 (47) 0.08
Biochemistry
 Blood sugar, mg/dL 110±74 100±27 110±49 0.1
 Bilirubin, mg/dL 0.3(0.2, 0.5) 0.4(0.2, 0.5) 0.4(0.2, 0.5) 0.55
 Platelets, x 109/L 229±76 240±67 234±66 0.28
 Leucocytes, x 109/L 6.35±1.99 6.38±1.72 6.53±1.92 0.68
 Reticulocytes, % 0.75±0.19 0.80±0.22 0.77±0.22 0.44
 Haemoglobin, g/L 140±14 142±14 142±12 0.13
 C reactive protein, mg/L 0(0, 0) 0(0, 0) 0(0, 0) 0.44
 Creatinine, mg/dL 0.9±0.3 0.9±0.2 0.9±0.2 0.59
 INR 1.02±0.12 1.01±0.10 1.02±0.10 0.3
Echocardiography
 LV ejection fraction <45%, % 9 (4) 6 (3) 3 (3) 0.69
 LV hypertrophy, % 9 (4) 4 (2) 4 (3) 0.39
 Diastolic dysfunction, % 7 (3) 5 (2) 1 (1) 0.43
 LV ejection fraction, % 57±6 57±5 58±5 0.48
 LV mass index, g/m2 71±18 68±17 70±16 0.11
 E/e’ 7.3±2.6 6.7±2.1 6.9±2.3 0.014
 E/A 1.2±0.5 1.3±0.4 1.3±0.4 0.003
 Left atrial volume index, mL/m2 20±6 19±5 19±4 0.025
 TR velocity, m/s 2.3±0.3 2.3±0.3 2.3±0.2 0.34

Normally distributed variables are displayed as mean±SD. Non-normally distributed variables are presented as median (IQR). Proportions are displayed as n (%).

*P for trend was calculated using linear regression models for normally distributed variables and Cuzick’s non-parametric test for trend for non-normally distributed variables.

A, late mitral inflow velocity; BMI, body mass index; COPD, chronic obstructive pulmonary disease; DBP, diastolic blood pressure; e', mitral annular early diastolic velocity; E, early mitral inflow velocity; INR, international normalised ratio; LV, left ventricular; MI, myocardial infarction; SBP, systolic blood pressure; TR, tricuspid regurgitation.